advertisement
Groth SL 7
Showing records 1 to 7 | Display all abstracts from Groth SL96331 Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes
Beykin G
American Journal of Ophthalmology 2021; 234: 223-234
96287 8-year follow-up of Excimer Laser Trabeculostomy Alone and Combined With Phacoemulsification in Patients with Open Angle Glaucoma
Berlin MS; Shakibkhou J
Journal of Cataract and Refractive Surgery 2022; 48: 838-843
96331 Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes
Stell L; Halim MS
American Journal of Ophthalmology 2021; 234: 223-234
96287 8-year follow-up of Excimer Laser Trabeculostomy Alone and Combined With Phacoemulsification in Patients with Open Angle Glaucoma
Tilakaratna N
Journal of Cataract and Refractive Surgery 2022; 48: 838-843
96331 Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes
Nuñez M
American Journal of Ophthalmology 2021; 234: 223-234
96287 8-year follow-up of Excimer Laser Trabeculostomy Alone and Combined With Phacoemulsification in Patients with Open Angle Glaucoma
Giers U; Groth SL
Journal of Cataract and Refractive Surgery 2022; 48: 838-843
96331 Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes
Popova L; Nguyen BT; Groth SL; Dennis A; Li Z; Atkins M; Khavari T; Wang SY; Chang R; Fisher AC; Sepah YJ; Goldberg JL
American Journal of Ophthalmology 2021; 234: 223-234